Organization and Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Changes in our Estimated Warranty Reserve

Changes in our estimated warranty reserve were as follows (in thousands):

	Year Ended December 31,
	2025		2024		2023
Balance, beginning of period	$	8,284	$	7,374	$	811
Utilization of reserve	(9,054)		(5,992)		(1,499)
Adjustment to reserve due to business combinations	—		1,311		—
Warranty expense	11,628		5,591		8,062
Balance, end of period	$	10,858	$	8,284	$	7,374

Schedule of Weighted Average Number of Shares Outstanding and Earnings Per Share

The calculation of the weighted average number of shares outstanding and earnings per share is as follows (in thousands except per share data):

	For the Year Ended December 31,
	2025		2024		2023
Numerator for basic and diluted earnings per share:
Net income	$	124,656	$	377,034	$	175,783
Denominator:
Weighted average shares outstanding	78,081		75,748		74,195
Dilutive effect of stock-based awards	1,826		1,435		1,261
Dilutive effect of 2027 Notes (1)	990		1,139		—
Dilutive effect of 2027 Warrants	1,473		236		—
Diluted weighted average shares outstanding	82,370		78,558		75,456
Net income per common share:
Basic	$	1.60	$	4.98	$	2.37
Diluted	$	1.51	$	4.80	$	2.33

(1)For the year ended December 31, 2025, the impacts of early repurchases of portions of the 2027 Notes are weighted based upon the number of days in each corresponding period of time for (a) the period between January 1, 2025 and the closing date of each of the respective repurchases, which include the total amount of shares issuable upon a conversion of all of the 2027 Notes; and (b) subsequent to the closing date of each of the respective repurchases through December 31, 2025, which include the amount of shares issuable upon a conversion of the 2027 Notes that remain outstanding after the respective early repurchases. Refer to Note 10 for additional details.

Schedule of Potentially Dilutive Securities excluded in Calculation of Diluted Net Income Per Share

Potentially dilutive securities that are not included in the calculation of diluted net income per share because doing so would be antidilutive are as follows (in thousands):

	For the Year Ended December 31,
	2025	2024	2023
Stock-based awards	3,140	4,132	1,014
2027 Notes	141	1,877	3,017
2027 Warrants	1,544	2,781	3,017
Total potentially dilutive securities	4,825	8,790	7,048